Skip to main content
DNLI logo

DNLI · Denali Therapeutics Inc.

Track DNLI — free
$24.36 -0.05 (-0.18%)
Market Cap
$3.88B
Shares
159.85M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-02-05 CAROLE HO 39,490
2026-02-04 CAROLE HO 150,000
2026-02-03 CAROLE HO 150,000
2026-01-06 Ho Carole 17,218
2026-01-06 Schuth Alexander O. 17,218
2026-01-06 Watts Ryan J. 35,198
2025-12-04 CAROLE HO 1,882
2025-08-13 CAROLE HO 806
2025-08-12 Ho Carole 2,937
2025-08-12 Schuth Alexander O. 2,937
2025-07-09 Watts Ryan J. 495,282
2025-01-07 Schuth Alexander O. 12,255
2025-01-07 Ho Carole 2,907
2025-01-07 Watts Ryan J. 7,650
2025-01-07 Krognes Steve E. 3,339
2025-01-07 Watts Ryan J. 29,266
2025-01-07 Ho Carole 12,255
2025-01-07 Schuth Alexander O. 2,907
2025-01-02 VICKI LEE SATO 6,160
2024-12-31 STEVE KROGNES 30,000
2024-11-12 DAVID SCHENKEIN 59,441
2024-11-07 ALEXANDER SCHUTH 15,558
2024-10-18 RYAN WATTS 40,000
2024-09-30 STEVE KROGNES 30,000
2024-09-13 VICKI LEE SATO 6,160
2024-08-21 ALEXANDER SCHUTH 2,547
2024-08-21 CAROLE HO 20,005
2024-08-20 Watts Ryan J. 2,260
2024-08-20 Schuth Alexander O. 2,453
2024-08-20 Ho Carole 2,453
2024-08-20 Krognes Steve E. 1,727
2024-08-20 ALEXANDER SCHUTH 3,353
2024-08-13 Schuth Alexander O. 2,272
2024-08-13 Ho Carole 2,337
2024-07-01 STEVE KROGNES 30,000
2024-07-01 VICKI LEE SATO 6,160
2024-06-06 JENNIFER COOK 1,458
2024-04-15 VICKI LEE SATO 3,340
2024-04-01 STEVE EDWARD KROGNES 92,500
2024-02-14 Ho Carole 1,405
2024-02-14 ALEXANDER SCHUTH 20,128
2024-02-13 Watts Ryan J. 9,589
2024-02-13 Schuth Alexander O. 2,716
2024-02-13 Ho Carole 2,784
2024-02-13 Krognes Steve E. 2,750
2024-01-16 VICKI LEE SATO 4,998
2024-01-10 CAROLE HO 4,668
2024-01-09 Watts Ryan J. 7,818
2024-01-05 Ho Carole 9,972
2024-01-05 Krognes Steve E. 3,208
Showing 1–50 of 74 filings
Key facts CIK 1714899 CUSIP 24823R105 13F (30d) 275 filings 271 filers Visit website Investor relations